Huy X Ngo
Huy X Ngo
University of San Francisco
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents
NT Chandrika, SK Shrestha, HX Ngo, S Garneau-Tsodikova
Bioorganic & medicinal chemistry 24 (16), 3680-3686, 2016
572016
A complex game of hide and seek: the search for new antifungals
HX Ngo, S Garneau-Tsodikova, KD Green
MedChemComm 7 (7), 1285-1306, 2016
402016
Alkylated piperazines and piperazine-azole hybrids as antifungal agents
N Thamban Chandrika, SK Shrestha, HX Ngo, OV Tsodikov, KC Howard, ...
Journal of medicinal chemistry 61 (1), 158-173, 2018
262018
Identification of Ebsulfur Analogues with Broad‐Spectrum Antifungal Activity
HX Ngo, SK Shrestha, S Garneau‐Tsodikova
ChemMedChem 11 (14), 1507-1516, 2016
232016
Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis …
A Garzan, MJ Willby, HX Ngo, CS Gajadeera, KD Green, SYL Holbrook, ...
ACS infectious diseases 3 (4), 302-309, 2017
192017
Novel fluconazole derivatives with promising antifungal activity
NT Chandrika, SK Shrestha, HX Ngo, KC Howard, S Garneau-Tsodikova
Bioorganic & medicinal chemistry 26 (3), 573-580, 2018
152018
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus
HX Ngo, SK Shrestha, KD Green, S Garneau-Tsodikova
Bioorganic & medicinal chemistry 24 (24), 6298-6306, 2016
112016
Potent 1,2,4-Triazino[5,6b]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis
HX Ngo, KD Green, CS Gajadeera, MJ Willby, SYL Holbrook, C Hou, ...
ACS infectious diseases 4 (6), 1030-1040, 2018
102018
Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4)
MS Frasinyuk, W Zhang, P Wyrebek, T Yu, X Xu, VM Sviripa, ...
Organic & biomolecular chemistry 15 (36), 7623-7629, 2017
72017
Interfering with DNA decondensation as a strategy against mycobacteria
EM Scutigliani, ER Scholl, AE Grootemaat, S Khanal, JA Kochan, ...
Frontiers in Microbiology 9, 2034, 2018
52018
What are the drugs of the future?
HX Ngo, S Garneau-Tsodikova
MedChemComm 9 (5), 757-758, 2018
52018
N, N′-diaryl-bishydrazones in a biphenyl platform: broad spectrum antifungal agents
NT Chandrika, EK Dennis, SK Shrestha, HX Ngo, KD Green, ...
European journal of medicinal chemistry 164, 273-281, 2019
42019
Predicted Magnetic Fields of Loop Currents for Cuprate Superconductivity: A MaxEnt-μSR GdBCO Study
T Songatikamas, C Boekema, J Wong, H Ngo, MC Browne
Journal of superconductivity and novel magnetism 23 (5), 793-797, 2010
42010
Flipping the Switch “On” for Aminoglycoside-Resistance Enzymes: The Mechanism Is Finally Revealed!
HX Ngo, S Garneau-Tsodikova
Structure 24 (7), 1011-1013, 2016
32016
Emerging targets in anti-tubercular drug design
KD Green, SYL Holbrook, HX Ngo, S Garneau-Tsodikova
Antibiotic Drug Discovery, 141-203, 2017
22017
Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis from Mycobacterium tuberculosis
A Punetha, HX Ngo, SYL Holbrook, KD Green, MJ Willby, SA Bonnett, ...
ACS Chemical Biology, 2020
12020
Identification of ebsulfur analogues with broad-spectrum antifungal activity
S Garneau-Tsodikova, HX Ngo, SK Shrestha
US Patent 10,544,112, 2020
2020
Synthesis and Biological Evaluation of Novel Drug Candidates to Address Drug Resistance in Tuberculosis and Fungal Diseases
H Ngo
2018
Back Cover: Identification of Ebsulfur Analogues with Broad‐Spectrum Antifungal Activity (ChemMedChem 14/2016)
HX Ngo, SK Shrestha, S Garneau‐Tsodikova
ChemMedChem 11 (14), 1577-1577, 2016
2016
Development of ebsulfur analogues as potent antibacterials against
HX Ngo, SK Shrestha, KD Green, S Garneau-Tsodikova
2016
The system can't perform the operation now. Try again later.
Articles 1–20